A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

References

• The World Health OrganizationThe top ten causes of death fact sheet2004 Available at: http://www.who.int/mediacentre/factsheets/fs310/en/index.htmlAccessed January 18, 2013
   Google Scholar
• Lloyd-JonesDAdamsRJBrownTMExecutive summary: heart disease and stroke statistics – 2010 update: a report from the American Heart AssociationCirculation2010121794895420177011
   PubMed Web of Science ®Google Scholar
• Lioyd-JonesDMLarsonMGBeiserALevyDLifetime risk of developing coronary heart diseaseLancet19993539147899210023892
   PubMed Web of Science ®Google Scholar
• SerruysPWKutrykMJOngATLCoronary-artery stentsN Engl J Med2006354548349516452560
   PubMed Web of Science ®Google Scholar
• MoliternoDJHealing Achilles – sirolimus versus paclitaxelN Engl J Med2005353772472716105991
   PubMed Web of Science ®Google Scholar
• ArjomandHTuriZMcCormickDGoldbergSPercutaneous coronary intervention: historical perspectives, current status, and future directionAm Heart J2003146578779614597926
   PubMed Web of Science ®Google Scholar
• HillRADundarYBakhaiADicksonRWalleyTDrug-eluting stents: an early systematic review to inform policyEur Heart J2004251190291915172462
   PubMed Web of Science ®Google Scholar
• McFaddenEPStabileERegarELate thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyLancet200436494441519152115500897
   PubMed Web of Science ®Google Scholar
• TsimikasSDrug-eluting stents and late adverse clinical outcomes: lessons learned, lessons awaitedJ Am Coll Cardiol200647102112211516697332
   PubMed Web of Science ®Google Scholar
• SilberSAlbertssonPAvilesFFGuidelines for percutaneous interventions. The task force for percutaneous coronary interventions of the European Society of CardiologyEur Heart J200526880484715769784
   PubMed Web of Science ®Google Scholar
• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA2005293172126213015870416
   PubMed Web of Science ®Google Scholar
• MenownIBNoadRGarciaEJMeredithIThe platinum chromium element stent platform: from alloy, to design, to clinical practiceAdv Ther201027312914120437213
   PubMed Web of Science ®Google Scholar
• KastratiAMehilliJDirschingerJIntracoronay stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trialCirculation2001103232816282111401938
   PubMed Web of Science ®Google Scholar
• KastratiASchomigADirschingerJIncreased risk of restenosis after placement of gold-coated stentsCirculation2000101212478248310831521
   PubMed Web of Science ®Google Scholar
• O’BrienBJStinsonJSLarsenSREppihimerMJCarrollWMA platinum-chromium steel for cardiovascular eventsBiomaterials201031143755376120181394
   PubMed Web of Science ®Google Scholar
• StettlerCWandelSAllemannSOutcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisLancet2007370959193794817869634
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet2010375971020120920060578
   PubMed Web of Science ®Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med2010362181663167420445180
   PubMed Web of Science ®Google Scholar
• JensenLOThayssenPHansenHSRandomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)Circulation2012125101246125522308301
   PubMed Web of Science ®Google Scholar
• BangaloreSKumarSFusaroMShort- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trialsCirculation2012125232873289122586281
   PubMed Web of Science ®Google Scholar
• CamenzindEWijnsWMauriLStent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialLancet201238098511396140522951082
   PubMed Web of Science ®Google Scholar
• LeonMBNikolskyECutlipDEImproved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trialJACC Cardiovasc Interv20103101043105020965463
   PubMed Web of Science ®Google Scholar
• SerruysPBuszmanPLinkeA5-year follow-up from a prospective, randomized trial of biolimus A9-eluting stents with a biodegradable polymer vs sirolimus-eluting stents with a durable polymer-final report of the LEADERS study [abstract]J Am Coll Cardiol201260Suppl 17B13B14
   Web of Science ®Google Scholar
• RogersCDOptimal stent design for drug deliveryRev Cardiovasc Med20045Suppl 2S9S1515184829
   PubMedGoogle Scholar
• KotaniJAwataMNantoSIncomplete neointimal coverage of sirolimus-eluting stents: angioscopic findingsJ Am Coll Cardiol200647102108211116697331
   PubMed Web of Science ®Google Scholar
• FinnAVJonerMNakazawaGPathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelializationCirculation200711582435244117438147
   PubMed Web of Science ®Google Scholar
• DaemenJWenaweserPTsuchidaKEarly and late stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort studyLancet2007369956266767817321312
   PubMed Web of Science ®Google Scholar
• KingSB3rdSmithSCJrHirshfeldJWJr2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelinesJ Am Coll Cardiol200851217220918191745
   PubMed Web of Science ®Google Scholar
• Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC)European Association for Cardio-Thoracic Surgery (EACTS)European Association for Percutaneous Cardiovascular Interventions (EAPCI)WijnsWKolhPDanchinNGuidelines on myocardial revascularizationEur Heart J201031202501255520802248
   PubMed Web of Science ®Google Scholar
• WindeckerSSerruysPWWandelSBiolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialLancet200837296441163117318765162
   PubMed Web of Science ®Google Scholar
• KrucoffMWKereiakesDJPetersenJLA novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyJ Am Coll Cardiol200851161543155218420096
   PubMed Web of Science ®Google Scholar
• GrubeESchoferJHauptmannKENovel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stentJACC Cardiovasc Interv20103443143820398872
   PubMed Web of Science ®Google Scholar
• StefaniniGGByrneRASerruysPWBiodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trialsEur Heart J201233101214122222447805
   PubMed Web of Science ®Google Scholar
• LupiARognoniASeccoGGBiodegradable versus durable polymer drug eluting stents in coronary artery disease: Insights from a meta-analysis of 5834 patientsEur J Prev Cardiol2013 [Epub November 14, 2012]
   Web of Science ®Google Scholar
• CarrieDBerlandBVerheyeSA multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesionsJ Am Coll Cardiol201259151371137622284328
   PubMed Web of Science ®Google Scholar
• SchulerWSedraniRCottensSSDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivoTransplantation199764136429233698
   PubMed Web of Science ®Google Scholar
• MarxSOMarksARBench to bedside: the development of rapamycin and its application to stent restenosisCirculation2001104885285511514367
   PubMed Web of Science ®Google Scholar
• CarterAJTOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?Catheter Cardiovasc Interv200461223323614755819
   PubMed Web of Science ®Google Scholar
• WaksmanRPakalaRBaffourROptimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteriesCardiovasc Revasc Med20067317918416945826
   PubMedGoogle Scholar
• VerheyeSMartinetWKockxMMSelective clearance of macrophages in atherosclerotic plaques by autophagyJ Am Coll Cardiol200749670671517291937
   PubMed Web of Science ®Google Scholar
• KahanBDWongRLCarterCA phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipientsTransplantation19996881100110610551636
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA2008299161903191318430909
   PubMed Web of Science ®Google Scholar
• BaberUMehranRSharmaSKImpact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trialsJ Am Coll Cardiol201158151569157721924575
   PubMed Web of Science ®Google Scholar
• PalmeriniTKirtaneAJSerruysPWStent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trialsCirc Cardiovasc Interv20125335736422668554
   PubMed Web of Science ®Google Scholar
• XieXGuidoinRNutleyMZhangZFluoropassivation and gelatin sealing of polyester arterial prostheses to skip preclotting and constrain the chronic inflammatory responseJ Biomed Mater Res B Appl Biomater201093249750920186827
   PubMed Web of Science ®Google Scholar
• Gutiérrez-ChicoJLvan GeunsRJRegarETissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trialEur Heart J201132192454246321659439
   PubMed Web of Science ®Google Scholar
• ChenY-LFossAEppihimerMCharacterization of in vivo poly(dl-lactic-co-glycolic acid) bioabsorption from a drug-eluting stentEuroIntervention20128Suppl NN043
   Google Scholar
• StoneGWTeirsteinPSMeredithITA prospective randomized evaluation of a novel everolimus-eluting stent: the PLATINUM (a prospective, randomized, multicenter trial to assess an everlimus-eluting coronary stent system [Promus Element] for the treatment of up to two de novo coronary artery lesions) trialJ Am Coll Cardiol201157161700170821470815
   PubMed Web of Science ®Google Scholar
• StoneGWTeirsteinPSMeredithITTwo-year results of the PLATINUM randomized trial comparing platinum chromium promus element and cobalt chromium PROMUS/XIENCE V everolimus-eluting stents in de novo coronary artery lesionsJ Am Coll Cardiol20125913 Suppl 1E323
   Web of Science ®Google Scholar
• StoneGWEllisSGCannonLComparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialJAMA2005294101215122316160130
   PubMed Web of Science ®Google Scholar
• CannonLKereiakesDJMannTA prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: The PERSEUS Small Vessel TrialEuroIntervention20116892092721330238
   PubMed Web of Science ®Google Scholar
• CannonLASimonDIKereiakesDThe XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trialCatheter Cardiovasc Interv201280454655322121027
   PubMed Web of Science ®Google Scholar
• WykrzykowskaJJSerruysPWOnumaYImpact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer, the LEADERS trial substudyJACC Cardiovasc Interv20092986187019778775
   PubMed Web of Science ®Google Scholar
• MeredithITeirsteinPStoneGTwo-year results of the PLATINUM small vessel trial: evaluation of a 2.25 mm platinum chromium everolimus-eluting stent in de novo coronary artery lesionsEuroIntervention20128Suppl NN161
   Google Scholar
• KimYHParkSWLeeSWSirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery diseaseCirculation2006114202148215317060388
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialEuroIntervention200511586519758878
   PubMedGoogle Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialEuroIntervention20062328629419755303
   PubMedGoogle Scholar
• MeredithITWhitbournRScottDPLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenosesEuroIntervention201171849021550907
   PubMed Web of Science ®Google Scholar
• MeredithITVerheyeSDuboisCLPrimary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stentJ Am Coll Cardiol201259151362137022341736
   PubMed Web of Science ®Google Scholar
• VerheyeSMeredithITWeissmanNJSix-month IVUS and 12-month clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentEuroIntervention20128Suppl NN42
   Google Scholar
• HanrattyCGWalshSJLongitudinal compression: a “new” complication with modern coronary stent platforms – time to think beyond deliverability?EuroIntervention20117787287721970984
   PubMed Web of Science ®Google Scholar
• WilliamsPDMamasMAMorganKPLongitudinal stent deformation: a retrospective analysis of frequency and mechanismsEuroIntervention20128226727422052084
   PubMed Web of Science ®Google Scholar
• MamasMAWilliamsPDLongitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience databaseEuroIntervention20128219620422381263
   PubMed Web of Science ®Google Scholar
• PrabhuSSchikorrTMahmoudTJacobsJPotgieterASimontonCEngineering assessment of the longitudinal compression behaviour of contemporary coronary stentsEuroIntervention20128227528122057097
   PubMed Web of Science ®Google Scholar
• OrmistonJAWebberBWebsterMWStent longitudinal integrity. bench insights into a clinical problemJACC Cardiovasc Interv20114121310131722136972
   PubMed Web of Science ®Google Scholar
• KereiakesDJPopmaJJCannonLALongitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trialsEuroIntervention20128218719522445912
   PubMed Web of Science ®Google Scholar